These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 17707716)
1. Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging. Bragheto AM; Caserta N; Bahamondes L; Petta CA Contraception; 2007 Sep; 76(3):195-9. PubMed ID: 17707716 [TBL] [Abstract][Full Text] [Related]
2. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis]. Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919 [TBL] [Abstract][Full Text] [Related]
3. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Sheng J; Zhang WY; Zhang JP; Lu D Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671 [TBL] [Abstract][Full Text] [Related]
4. [Clinical study of levonorgestrel-releasing intrauterine system for adenomyosis]. He SM; Zhang YD Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1794-6. PubMed ID: 17259122 [TBL] [Abstract][Full Text] [Related]
5. [Levonorgestrel-releasing intrauterine system for treatment of dysmenorrhea associated with adenomyosis]. Sheng J; Lu D; Zhang JP; Cui GF Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):467-70. PubMed ID: 17083813 [TBL] [Abstract][Full Text] [Related]
6. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea. Bahamondes L; Petta CA; Fernandes A; Monteiro I Contraception; 2007 Jun; 75(6 Suppl):S134-9. PubMed ID: 17531605 [TBL] [Abstract][Full Text] [Related]
7. Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis. Cho S; Nam A; Kim H; Chay D; Park K; Cho DJ; Park Y; Lee B Am J Obstet Gynecol; 2008 Apr; 198(4):373.e1-7. PubMed ID: 18177833 [TBL] [Abstract][Full Text] [Related]
8. Treatment of primary and secondary dysmenorrhea with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study. Wildemeersch D; Schacht E; Wildemeersch P Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):192-8. PubMed ID: 11848648 [TBL] [Abstract][Full Text] [Related]
9. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas. Magalhães J; Aldrighi JM; de Lima GR Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488 [TBL] [Abstract][Full Text] [Related]
10. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Petta CA; Ferriani RA; Abrao MS; Hassan D; Rosa E Silva JC; Podgaec S; Bahamondes L Hum Reprod; 2005 Jul; 20(7):1993-8. PubMed ID: 15790607 [TBL] [Abstract][Full Text] [Related]
11. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)]. Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443 [TBL] [Abstract][Full Text] [Related]
12. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis. Kelekci S; Kelekci KH; Yilmaz B Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203 [TBL] [Abstract][Full Text] [Related]
13. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system. Fong YF; Singh K Contraception; 1999 Sep; 60(3):173-5. PubMed ID: 10640162 [TBL] [Abstract][Full Text] [Related]
14. The Femilis LNG-IUS: contraceptive performance-an interim analysis. Wildemeersch D; Janssens D; Andrade A Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705 [TBL] [Abstract][Full Text] [Related]
15. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system. de Jonge ET; Yigit R; Molenberghs G; Straetmans D; Ombelet W Contraception; 2007 Aug; 76(2):91-5. PubMed ID: 17656176 [TBL] [Abstract][Full Text] [Related]
16. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding. Busfield RA; Farquhar CM; Sowter MC; Lethaby A; Sprecher M; Yu Y; Sadler LC; Brown P; Johnson N BJOG; 2006 Mar; 113(3):257-63. PubMed ID: 16487195 [TBL] [Abstract][Full Text] [Related]
17. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia. Shaw RW; Symonds IM; Tamizian O; Chaplain J; Mukhopadhyay S Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692 [TBL] [Abstract][Full Text] [Related]
18. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study. Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693 [TBL] [Abstract][Full Text] [Related]
19. Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system. Wildemeersch D; Rowe PJ Contraception; 2005 Jun; 71(6):470-3. PubMed ID: 15914139 [TBL] [Abstract][Full Text] [Related]
20. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems. Wildemeersch D; Janssens D; Vrijens M; Weyers S Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]